Medicine and Dentistry
Quality of Life
44%
Spinal Cord Injury
42%
Neuropathic Pain
42%
Spasticity
33%
Continuous Positive Airway Pressure
33%
Meta-Analysis
33%
Chronic Obstructive Pulmonary Disease
33%
Lung Ventilation
33%
Image Quality
33%
Placebo Effect
33%
Technetium-99
33%
Single-Photon Emission Computed Tomography
33%
Palmitoylethanolamide
33%
Traumatic Spinal Cord Injury
33%
Injury
31%
Placebo
20%
Patient-Data
13%
Diagnosis
11%
Pulmonary Embolism
11%
Mucus
11%
Technetium
11%
Airway Dynamics
11%
Numeric Rating Scale
9%
Mental Health
9%
Chronic Pain
9%
Arm
6%
Endocannabinoid
6%
Clinical Trial
6%
Treatment Effect
6%
Controlled Clinical Trial
6%
Pharmacology, Toxicology and Pharmaceutical Science
Spinal Cord Injury
100%
Neuropathic Pain
77%
Placebo
66%
Palmitoylethanolamide
66%
Spasticity
50%
Multiple Sclerosis
33%
Cannabis
33%
Injury
22%
Chronic Pain
11%
Adverse Event
10%
Add on Therapy
8%
Prevalence
7%
Quadriplegia
5%
Cross Sectional Study
5%
Keyphrases
Ultramicronized Palmitoylethanolamide
33%
Palmitoylethanolamide
33%
Spasticity
33%
Add-on Therapy
11%
Numeric Rating Scale
11%
Efficacy Analysis
5%
Mean Reduction
5%
Pain Diary
5%
Fatty Acid Amides
5%
Physical Health Score
5%
Baseline Period
5%
Baseline Observation Carried Forward
5%
Three-parameter
5%
Life Situation
5%
Endocannabinoids
5%
Injury Characteristics
5%
Injury Time
5%
Self-reported Pain
5%
Difference in Mean
5%
Severe Pain
5%
Anonymous Survey
5%
Tetraplegia
5%
One Percent
5%
Average Interference
5%
Per-protocol Analysis
5%
Protocol Compliance
5%
Pain Score
5%
Insomnia
5%
Patient Global Impression of Change
5%
Sleep Problems
5%
